At a glance
- Originator Abbott GmbH & Co. KG
- Class Antiepileptic drugs; Imidazoles; Neuroprotectants; Quinoxalines; Small molecules
- Mechanism of Action AMPA receptor antagonists; Glycine gated NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 31 Dec 2012 Discontinued - Preclinical for Epilepsy in Germany (unspecified route) before 2012
- 04 Dec 2003 No development reported - Preclinical for Epilepsy in Germany (unspecified route)
- 13 Mar 2001 BASF's pharmaceutical business has been acquired by Abbott Laboratories